BCL2 and hepatocellular carcinoma: In contrast, silencing of miR-221 induces apoptosis and G2/M phase arrest and inhibits cellular proliferation by upregulating p53 and downregulating Bcl-2 in HCC cells, leading to increased OS, RFS, and PFS in patients [34].